Fritsch, K
Kasenda, B
Schorb, E
Hau, P
Bloehdorn, J
Möhle, R
Löw, S
Binder, M
Atta, J
Keller, U
Wolf, H-H
Krause, S W
Heß, G
Naumann, R
Sasse, S
Hirt, C
Lamprecht, M
Martens, U
Morgner, A
Panse, J
Frickhofen, N
Röth, A
Hader, C
Deckert, M
Fricker, H
Ihorst, G
Finke, J
Illerhaus, G
Article History
Received: 25 August 2016
Revised: 10 October 2016
Accepted: 21 October 2016
First Online: 15 November 2016
Competing interests
: SWK received travel support from Roche. UK reports personal fees from Roche, outside the submitted work. JF reports grants and personal fees from Riemser, grants and personal fees from Novartis, grants and personal fees from Neovii and grants from Medac, outside the submitted work. GH reports grants and personal fees from Roche, outside the submitted work. SK reports non-financial support from Roche, outside the submitted work. The other authors declare no conflict of interest.